Understanding Rett Syndrome: How MECP2 Mutations Drive Brain Disease
Official title: Understanding the Pathogenic Mechanisms of Rett Syndrome
Funded at University of Pennsylvania · NIH-11364233 · Data updated 2026-11-12
This grant explores how mutations in MECP2 cause Rett syndrome and aims to uncover the brain changes that lead to intellectual disability in affected individuals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2013 |
| Project end | April 30, 2030 |
| Funding year | 2026 |
| Award (this year) | $623,667 |
| NIH project number | 5R01NS081054-12 |
| Project ID | NIH-11364233 on NIH RePORTER |
Who could benefit from this research
✓Could help
Girls and women with Rett syndrome or MECP2-related neurodevelopmental issues, and researchers seeking to translate findings to patient care.
✕Less likely to help
The study is preclinical and may not directly yield a therapy during the grant period.
What this research studies
Rett syndrome is a neurodevelopmental disorder caused by MECP2 mutations, mainly affecting females. The project uses innovative mouse models with tagged neurons to separate wild-type and mutant cell signals, helping pinpoint how X-chromosome inactivation shapes disease progression. By tracking gene activity over time, researchers hope to map when and why symptoms emerge and how brain cells respond to MECP2 problems. This knowledge could guide future therapies that target the underlying mechanisms in patients.
Why it matters
Potential benefit: Insights from this work could inform treatments that slow or alter disease progression for people with Rett syndrome.
How similar studies have gone: Earlier approaches using cell-type and time-specific analysis have shown promise in revealing disease mechanisms in RTT models.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Zhou, Zhaolan — University of Pennsylvania
- Study coordinator: Zhou, Zhaolan
Related research
Other NIH-funded projects on the same topics.
-
Neuronal Cholesterol Enzyme CYP46A1 and Rett Syndrome biology
A study in Rett syndrome explores whether tweaking a brain cholesterol enzyme called CYP46A1 could help with the disease by affecting brain pathways involved in Rett.
-
Neurophysiological biomarkers to speed Rett syndrome therapies
A study to find measurable brain signals that show whether treatments are helping children with Rett syndrome.
-
MeCP2 reactivation on the inactive X to treat Rett syndrome
This project explores turning on the silent MECP2 gene on the inactive X chromosome to help people with Rett syndrome feel better.
-
Glial signaling and breathing in Rett syndrome
Aims to understand how brain support cells (glia) in Rett syndrome affect breathing and whether IGF-1 related signals can improve it.
-
Studying how deep brain stimulation helps Rett syndrome in mice
Researchers are testing how deep brain stimulation affects brain cells and memory in a mouse model of Rett syndrome to uncover mechanisms that could guide future therapies.
-
Molecular Pathways Behind Rett Syndrome in Humans
A patient-focused look at how changes in the MECP2 gene affect brain function and development in Rett syndrome.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.